| 000 | 01396 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250511190531.0 | ||
| 264 | 0 | _c19920924 | |
| 008 | 199209s 0 0 eng d | ||
| 022 | _a0954-6820 | ||
| 024 | 7 |
_a10.1111/j.1365-2796.1992.tb00560.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMathus-Vliegen, E M | |
| 245 | 0 | 0 |
_aDexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour. _h[electronic resource] |
| 260 |
_bJournal of internal medicine _cAug 1992 |
||
| 300 |
_a119-27 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
| 650 | 0 | 4 |
_aFeeding Behavior _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFenfluramine _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _avan de Voorde, K | |
| 700 | 1 | _aKok, A M | |
| 700 | 1 | _aRes, A M | |
| 773 | 0 |
_tJournal of internal medicine _gvol. 232 _gno. 2 _gp. 119-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2796.1992.tb00560.x _zAvailable from publisher's website |
| 999 |
_c1513290 _d1513290 |
||